Membrane activity of (Cys48Ser) lung surfactant protein B increases with dimerisation

Biol Chem. 2001 Jun;382(6):933-9. doi: 10.1515/BC.2001.116.

Abstract

One of the possible functions of lung surfactant protein B (SP-B), an hydrophobic membrane-associated saposin-like protein, is to reduce the alveolar surface tension by promoting insertion of phospholipids into the air/liquid interface of the lung. SP-B is a covalent homodimer; Cys48 of two polypeptides form an intermolecular disulphide bond. In order to test whether dimerisation of SP-B is important for surfactant function, transgenic mice which express (Cys48Ser) human SP-B in a mouse SP-B null background were generated. In previous studies (Cys48Ser)SP-B showed a concentration-dependent in vitro activity, suggesting that it may form non-covalent dimers. Here (Cys48Ser)SP-B isolated from bronchoalveolar lavage of transgenic mice was studied at different concentrations by circular dichroism (CD) spectroscopy, pulsating bubble surfactometry, mass spectrometry and reversed-phase HPLC. The results indicate that (Cys48Ser)SP-B, both in a phospholipid environment and in organic solvents, is largely monomeric and exhibits low activity at concentrations lower than 1 -2 microM, while at higher concentrations it forms non-covalent dimers, which are nearly functionally equivalent to native SP-B in vitro. Furthermore, electrospray mass spectrometry showed that more dimers were found relative to the monomer when the polarity of the solvent was decreased, and when the concentration of SP-B increased. (Cys48Ser)SP-B also eluted earlier than native SP-B in reversed-phase HPLC. Taken together, these results indicate that a polar surface is buried upon dimerisation, thereby promoting formation of interchain ion pairs between Glu51-Arg52' and Glu51'-Arg52.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Amino Acid Substitution
  • Animals
  • Cell Membrane / drug effects*
  • Circular Dichroism
  • Dimerization
  • Dose-Response Relationship, Drug
  • Membranes, Artificial
  • Mice
  • Mice, Transgenic
  • Protein Structure, Secondary
  • Proteolipids / chemistry
  • Proteolipids / genetics
  • Proteolipids / pharmacology*
  • Pulmonary Surfactants / chemistry
  • Pulmonary Surfactants / genetics
  • Pulmonary Surfactants / pharmacology*
  • Surface Tension / drug effects

Substances

  • Membranes, Artificial
  • Proteolipids
  • Pulmonary Surfactants